AXL Mediates Resistance to AKT inhibition in Oesophageal Adenocarcinoma.

Research output: Contribution to conferenceAbstract

Original languageEnglish
Publication statusPublished - 06 Nov 2017
EventNCRI Cancer Conference 2016 - Liverpool, United Kingdom
Duration: 06 Nov 201609 Nov 2016

Conference

ConferenceNCRI Cancer Conference 2016
CountryUnited Kingdom
CityLiverpool
Period06/11/201609/11/2016

Keywords

  • oesophageal cancer
  • Drug Resistance

Cite this